Cart
sales@molnova.com
Compound T72082(SC)
CAS No. 298193-11-0
Compound T72082(SC)( —— )
Catalog No. M36440 CAS No. 298193-11-0
ROS-IN-1 is a mitochondrial ROS inhibitor used to reduce oxidative stress or inhibit reactive oxygen species (ROS) production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 100 | In Stock |
|
| 50MG | 142 | In Stock |
|
| 100MG | 213 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 529 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound T72082(SC)
-
NoteResearch use only, not for human use.
-
Brief DescriptionROS-IN-1 is a mitochondrial ROS inhibitor used to reduce oxidative stress or inhibit reactive oxygen species (ROS) production.
-
DescriptionROS-IN-1 is a mitochondrial ROS inhibitor. ROS-IN-1 can reduce oxidative stress or inhibit reactive oxygen species (ROS) production.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetROS
-
RecptorROS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number298193-11-0
-
Formula Weight267.34
-
Molecular FormulaC13H17NO3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC(C)=C(C(C)=C1)S(=O)(=O)N1CCCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martin D, et al. Compounds and methods for modulating mitochondrial metabolism and reactive oxygen species production. Patent. US20140128352A1.
molnova catalog
related products
-
Taletrectinib free b...
Taletrectinib free base (AB-106 free base) is a novel potent, selective and orally active ROS1/NTRK inhibitor.
-
Mitoquinone mesylate
Mitoquinone mesylate is a TPP-based, mitochondrially targeted antioxidant to protect against oxidative damage.
-
Zidesamtinib
Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors.
